More and more young people in the United States go to the Smart Spring Wegovy of the Danish pharmaceutical company Novo Nordisk. Last year the number rose by 50 percent to 14.8 per 100,000 young people.
In the first three months of 2023 there were 17.3 new recipes per 100,000. At the end of 2022, Wegovy received approval for the treatment of children and adolescents of twelve in the United States. 23,000 of the 100,000 young people in the United States have pathologically overweight. This is almost everyone and every fourth youth. “If it is not enough to only change the lifestyle, we need these extra instruments,” says Cate Varney, director of obesity medicine of the University of Virginia.
However, some doctors hesitate to prescribe young people Wegovy because they are afraid of long -term side effects and the treatment may have to be unlimited. At the same time, health insurance companies often do not cover obesity.
Kennedy: “Out -Medicalization”
Minister of Health Robert Kennedy Jr. Also criticized the fact that Ozempic or Wegovy was prescribed to children and adolescents to treat obesity. That is an example of the “over -medication of our children”. There are also no data about the long -term effect and therefore the risk of unforeseen problems that damage or affect the metabolism and the development of growth.
The pharmaceutical company Novo Nordisk assumed that the active ingredient Semaglutid “had no influence on growth or puberty development” in clinical studies. With many adults, obesity starts in childhood or adolescence. Wegovy is part of medication that reduces blood sugar levels and reducing appetite. Other medicines in this category such as Ozempic from Novo or Zepbound by Eli Lilly were not admitted because they were not approved for the treatment of obesity in children and adolescents.
Source: Krone
I am Wallace Jones, an experienced journalist. I specialize in writing for the world section of Today Times Live. With over a decade of experience, I have developed an eye for detail when it comes to reporting on local and global stories. My passion lies in uncovering the truth through my investigative skills and creating thought-provoking content that resonates with readers worldwide.
